Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Cindy L Schwartz, Qinglin Pei, Frank G. Keller, Steve Y Cho, David C. Hodgson, Kathleen M McCarten, Yue Wu, Kara M. Kelly, Sharon M. Castellino

Blood (2022) 140 (Supplement 1): 6565–6566.

https://doi.org/10.1182/blood-2022-167188

Published: 2022

Journal Articles

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Akash Parekh, Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei, Yue Wu, Sharon M. Castellino, Louis S. Constine, Cindy L. Schwartz, David Hodgson, Kara M. Kelly, Bradford S. Hoppe

Blood (2022) 140 (10): 1086–1093.

https://doi.org/10.1182/blood.2022016098

Published: 2022

Includes: Supplemental data

Journal Articles

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Rebecca L. Johnston, Anja Mottok, Fong Chun Chan, Aixiang Jiang, Arjan Diepstra, Lydia Visser, Adèle Telenius, Randy D. Gascoyne, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly, David W. Scott, Terzah M. Horton, Christian Steidl

Blood (2022) 139 (6): 889–893.

https://doi.org/10.1182/blood.2021011941

Published: 2022

Includes: Supplemental data

Journal Articles

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Andrea C. Lo, Amy Liu, Qi Liu, Yutaka Yasui, Sharon M. Castellino, Kara M. Kelly, Alex F. Herrera, Jonathan W. Friedberg, Debra L. Friedman, Cindy L. Schwartz, Samuel Bergeron-Gravel, Hitesh Dama, Kenneth B. Roberts, Louis S. Constine, David Hodgson

Blood (2021) 138 (Supplement 1): 881.

https://doi.org/10.1182/blood-2021-147678

Published: 2021

Journal Articles

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu, Suzanne L. Wolden, Louis S. Constine, Kara M. Kelly, Cindy L. Schwartz, Debra L. Friedman

Blood (2021) 137 (11): 1449–1456.

https://doi.org/10.1182/blood.2020007225

Published: 2021

Includes: Supplemental data

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Lianna J. Marks, Kathleen M. McCarten, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly

Blood (2018) 132 (11): 1208–1211.

https://doi.org/10.1182/blood-2018-02-834465

Published: 2018

Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 607.

https://doi.org/10.1182/blood.V130.Suppl_1.607.607

Published: 2017

Journal Articles

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Lianna J. Marks, MD, Qinglin Pei, PhD, Allen Buxton, MS, Burton Appel, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 1814.

https://doi.org/10.1182/blood.V128.22.1814.1814

Published: 2016

Journal Articles

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Eric J Chow, MD MPH, David R. Doody, MS, Saro H. Armenian, DO, MPH, Sanjeev Aggarwal, MD, K. Scott Baker, MD MS, Smita Bhatia, MD MPH, Nancy A. Blythe, BA, Louis S. Constine, MD, David R. Freyer, DO, MS, Lisa M. Kopp, DO, Wendy M. Leisenring, ScD, Nao Sasaki, MD, Lynda M. Vrooman, MD MSc, Barbara L. Asselin, MD, Cindy L. Schwartz, MD MPH, Steven E. Lipshultz, MD FAAP, FAHA

Blood (2016) 128 (22): 696.

https://doi.org/10.1182/blood.V128.22.696.696

Published: 2016

Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 924.

https://doi.org/10.1182/blood.V128.22.924.924

Published: 2016

Journal Articles

Perspectives Regarding Fertility in Female Adolescent and Young Adult Childhood Cancer Survivors

Pooja Rao, MD, Priya Hirway, Jennifer JG Welch, MD, Cindy L Schwartz, MD MPH

Blood (2014) 124 (21): 1271.

https://doi.org/10.1182/blood.V124.21.1271.1271

Published: 2014

Journal Articles

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Lewis B. Silverman, MD, Kristen E. Stevenson, MS, Uma H. Athale, M.D., M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Kara A. Kelly, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy L Schwartz, MD, MPH, Barbara Asselin, MD, Jeffrey G Supko, PhD, Sarah Hunt, MPH, Place Andrew, MD, PhD, Lynda M. Vrooman, MD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD

Blood (2013) 122 (21): 838.

https://doi.org/10.1182/blood.V122.21.838.838

Published: 2013

Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD

Blood (2012) 120 (21): 1530.

https://doi.org/10.1182/blood.V120.21.1530.1530

Published: 2012

Journal Articles

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

Lewis B. Silverman, Jeffrey G. Supko, Kristen E. Stevenson, Christina Woodward, Lynda M. Vrooman, Donna S. Neuberg, Barbara L. Asselin, Uma H. Athale, Luis Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdière, Bruno Michon, Marshall Schorin, Cindy L. Schwartz, Jane E. O'Brien, Harvey J. Cohen, Stephen E. Sallan

Blood (2010) 115 (7): 1351–1353.

https://doi.org/10.1182/blood-2009-09-245951

Published: 2010

Journal Articles

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna, Wendy B. London, Robert E. Hutchison, Richard Sposto, Steven E. Lipshultz, Charles S. Turner, Pedro A. deAlarcon, Allen Chauvenet

Blood (2009) 114 (10): 2051–2059.

https://doi.org/10.1182/blood-2008-10-184143

Published: 2009

Includes: Supplemental data

Journal Articles

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Peter D. Cole, MD, Tanya M. Trippett, MD, Richard A. Drachtman, MD, Pedro de Alarcon, MD, Lu Chen, Cindy L. Schwartz, MD

Blood (2007) 110 (11): 2318.

https://doi.org/10.1182/blood.V110.11.2318.2318

Published: 2007

Journal Articles

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Shirley Hogan, PharmD, Joy Mitchell, CRA, Vickie Massey, MD, Louis S. Constine, MD, Lu Chen, PhD, Cindy L. Schwartz, MD

Blood (2007) 110 (11): 1896.

https://doi.org/10.1182/blood.V110.11.1896.1896

Published: 2007

NARROW

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Perspectives Regarding Fertility in Female Adolescent and Young Adult Childhood Cancer Survivors

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only